Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1 3Phase 2/3 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 6Prostatic Neoplasms 4Rectal Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma, Ovarian 1Teratoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

Colonoscopy 44Standard of Care 28Early Intervention, Educational 23Methods 22Blood Specimen Collection 21Exercise 20Educational Status 19Interviews as Topic 13Surveys and Questionnaires 12Patient Navigation 12Counseling 12Practice Guidelines as Topic 11Endoscopic Mucosal Resection 10Drug Therapy 10Oxaliplatin 9Irinotecan 8Fluorouracil 8Surgical Procedures, Operative 7Preoperative Exercise 7Lidocaine 7Bevacizumab 7Therapeutics 6Resistance Training 6Occult Blood 6Narrow Band Imaging 6Mass Screening 6Leucovorin 6Diet 6Decision Support Techniques 6Control Groups 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Colorectal Neoplasms × Gene Expression Profiling × Clear all
NCT00628368 2026-02-10

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
160 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01280643 2021-03-15

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Fox Chase Cancer Center

Phase NA Terminated
3 enrolled 8 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00608595 2013-03-05

Celecoxib in Treating Patients With Early-Stage Rectal Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
10 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡